Introducing Fagron Hospital Solutions: SyrSpend® SF Convenience Packs

Mon, 03/23/2015

St. Paul, MN, March 23, 2015

With a focus on patient, pharmacist, and prescriber, Fagron, Inc. offers unique solutions that add significant value in the treatment of patients with special needs. Fagron’s just-add-water convenience packs offer the pharmacist convenient and time-saving solutions to help patients while decreasing the possibility of errors. Our convenience packs cover a wide range of treatments from oral suspensions to topical anesthetics. With a global focus on innovation, we are driven to continuously provide pharmacists with the best solutions in compounding.

 

Our SyrSpend® SF line of convenience packs offer all the benefits of our best-selling suspending vehicle in a unique, preservative-free option. As always, all of the SyrSpend® SF vehicles are dye-free, sorbitol- and sugar-free, and alcohol-free, providing acceptability for a wide range of patients. The unique starch-based suspending vehicle uses patented Active Suspending Technology™ to assist in keeping the active pharmaceutical ingredients (APIs) in suspension for longer, allowing for more accurate and consistent dosing for the duration of treatment.

 

Fagron, Inc. provides pharmacists in the United States with high quality compounding products and solutions.

 

Fagron continuously introduces innovative products based on research done in our own R&D center. We work together with our customers,  physicians, and other healthcare providers to deliver optimized compounding solutions with high quality results. We continuously perform studies on our products, and we are dedicated to providing you with innovative compounding solutions. To find out more, visit our website at: Fagron.us and contact us for more information.
 

Fagron, Inc. - USA

Fagron, Inc., is headquartered in St. Paul, Minnesota. Since 1980, Fagron, Inc. has been a US Food and Drug Administration-registered pharmaceutical supplier, adhering strictly to current Good Manufacturing Practices (cGMP). Bulk Pharmaceutical Ingredients (BPI) are purchased from reputable, registered, and validated manufacturers.

Fagron’s strategy is focused on the optimisation and innovation of pharmaceutical compounding. As a R&D scientific pharmaceutical compounding supplier, Fagron wants to widen the therapeutic scope of the prescriber to enable tailor-made pharmaceutical care. Through its activities, Fagron supports the unique selling point of the pharmacist and improves the patient’s quality of life.

 

For more information about Fagron, Inc. please visit:

https://us.fagron.com/en-us


Contact
Fagron, Inc.
marketing@fagron.us